AstraZeneca 'mulling partnerships'
China Daily | Updated: 2009-12-11 08:02
|
AstraZeneca's cholesterol pill Crestor is shown in a Cambridge, Massachusetts pharmacy. The UK drugmaker prefers licensing deals to acquisitions. Bloomberg News |
LONDON: AstraZeneca Plc is in "exploratory discussions" with competitors for partnerships that would help ease the cost and risk of developing new medicines, said Shaun Grady, vice-president of corporate business development.
Photo
